INTRODUCTION
Glutamate released at excitatory synapses acts on ligand-gated ionotropic receptors, which fall into three classes, named after their preferred or selective agonist: a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl D-aspartate (NMDA), and kainate. Like other neurotransmitter receptors, ionotropic glutamate receptors harbor binding sites for small molecules that act as allosteric regulators of receptor function. Allosteric modulators are likely to play a key role in the regulation of synaptic transmission and moreover represent potential pharmacological tools of great interest. Positive allosteric modulators of AMPA, kainate, and NMDA receptors (NMDARs) are thought to be promising therapeutic agents in the treatment of cognitive dysfunctions (Traynelis et al., 2010) . It is thus important to increase our understanding of the molecular mechanisms by which physiologically relevant allosteric modulators are engaged in the regulation of synaptic transmission.
Ionotropic glutamate receptors are mainly localized at postsynaptic sites where they are directly involved in the transfer of information across synapses. There is however increasing evidence that ionotropic glutamate receptors are also present at presynaptic sites, where they regulate the release of neurotransmitters and participate in presynaptic forms of plasticity (Pinheiro and Mulle, 2008) . In the brain, kainate receptors (KARs) support a variety of functions contributing to the regulation of the activity of synaptic networks (Contractor et al., 2011) . KARs are tetramers composed of a combination of the five subunits, GluK1-GluK5, previously GluR5-GluR7,KA1-KA2 (Contractor et al., 2011) . KARs share a similar architecture with other ionotropic glutamate receptors; the subunits have a large extracellular domain composed of an amino-terminal domain (ATD) and a ligand binding domain (LBD), a membrane region composed of three membrane a helices and a reentrant loop, and an intracellular carboxy-terminal region (Mayer, 2011) . The various roles of KARs at pre-or postsynaptic sites arise in part from the diversity of functional properties of the different KAR subtypes (Perrais et al., 2010) . At hippocampal mossy fiber synapses onto CA3 pyramidal cells, KARs are present at both pre-and postsynaptic levels (Contractor et al., 2011) . Postsynaptic KARs are composed of the GluK2, GluK4, and GluK5 subunits (Contractor et al., 2003; Fernandes et al., 2009; Mulle et al., 1998) , whereas presynaptic KARs are thought to comprise the GluK2 and GluK3 subunits (Contractor et al., 2001; Pinheiro et al., 2007) . The functional properties of GluK3 (and GluK2/ GluK3) receptors set it apart from the other ionotropic glutamate receptors (Perrais et al., 2009a; Schiffer et al., 1997) . In particular, its sensitivity to glutamate is the lowest of all known ionotropic glutamate receptors, due in large part to fast desensitization of receptors with only one or two bound glutamate molecules (Perrais et al., 2009a) . The low agonist sensitivity of this receptor raises questions about its relevance for synaptic function (Perrais et al., 2010) . Therefore, it is possible that endogenous modulators may potentiate its responsiveness to glutamate.
Among potential endogenous modulators of KAR function, we chose to address the role of zinc, known to be present in large amounts in hippocampal mossy fiber terminals (Paoletti et al., 2009) . Zinc is accumulated into synaptic vesicles and thought to be coreleased with glutamate in the extracellular milieu during neuronal activity (Paoletti et al., 2009 ). The bestcharacterized synaptic zinc targets are NMDARs (Westbrook and Mayer, 1987) . Zinc inhibits NMDAR function with affinities ranging from low nanomolar for GluN1/GluN2A receptors to low micromolar for GluN1/GluN2B subunits (Paoletti et al., 1997) . The binding site accounting for the high-affinity binding of zinc to GluN2A and GluN2B has been mapped to the large ATD of GluN2 subunits (Choi and Lipton, 1999; Karakas et al., 2009; Paoletti et al., 2000; Rachline et al., 2005) . Zinc binding to the ATD has been suggested to inhibit NMDAR channel gating through destabilization of the dimer interface of the LBD (Erreger et al., 2005; Gielen et al., 2008) , by mechanisms that resemble desensitization of AMPA and KARs (Armstrong et al., 2006; Weston et al., 2006) . Zinc has also been reported to inhibit native and recombinant KARs. Zinc inhibition of KARs is subunit dependent, with KARs containing GluK4 or GluK5 subunits being more sensitive, IC 50 $1-2 mM, than GluK1-GluK2, IC 50 $70 mM (Mott et al., 2008) . Despite the proposed presynaptic function of GluK3-containing KARs at hippocampal mossy fiber synapses, which are highly enriched in vesicular zinc, modulation of these receptors by zinc has not yet been addressed.
In this study, we show that zinc at micromolar concentrations potentiates recombinant GluK3 receptor currents evoked by glutamate. Zinc markedly slows receptor desensitization and increases apparent affinity for glutamate. By analysis of chimeric GluK2/GluK3 KARs and of GluK3 bearing selected point mutations, we mapped the zinc binding domain to the S2 segment of the LBD, in a region forming the interface between two GluK3 subunits in an LBD dimer assembly. Crystallographic studies for GluK3 LBD complexes with both glutamate and kainate revealed that zinc ions bind at multiple sites formed by aspartate, histidine, and glutamate residues, which are present in both the upper and lower lobes of the LBD. Based on these crystal structures, a GluK3 LBD dimer model was generated by superposition of GluK3 monomers on previously solved KAR LBD dimers. This identified D730 as the dimer partner component of the binding site underlying zinc potentiation, together with D759 and H762 from the adjacent subunit. Based on these structure-function studies and on modeling of KAR activity, we show that zinc plays a very distinct role in GluK3-KARs by stabilizing the LBD dimer assembly, thereby reducing desensitization. Given the proposed presynaptic localization of GluK3 close to zinc-containing synaptic vesicles, zinc may be an endogenous allosteric modulator for native GluK3-KARs.
RESULTS

Zinc Reversibly Facilitates Recombinant GluK3 Receptor Currents
We tested the effect of zinc on currents activated by fast application of glutamate on lifted HEK293 cells transfected with GluK3 cDNA. Currents evoked by sustained applications (100 ms) of 10 mM glutamate, a concentration close to the EC 50 value for GluK3 (Perrais et al., 2009a; Schiffer et al., 1997) , were markedly enhanced with preapplication of 100 mM zinc ( Figure 1A ; 193% ± 38% of control amplitude, n = 17), and this potentiation was rapidly reversible upon removal of zinc. In contrast to GluK3 potentiation, and as previously reported in Xenopus oocytes (Mott et al., 2008) , zinc reversibly inhibited GluK2 currents at all concentrations tested ( Figures 1A and 1D) , with an IC 50 of 102 ± 11 mM and a Hill coefficient (nH) of 1.1 ± 0.1 (n = 4-9). Because a glutamate concentration of 10 mM is saturating for GluK2 (Perrais et al., 2009a) , this could mask a potentiating effect of zinc. However, currents evoked by 500 mM glutamate, a concentration below the EC 50 for GluK2, were also inhibited by 100 mM zinc (48% ± 10%, n = 10; data not shown). It has been proposed that presynaptic GluK2/GluK3 heteromeric receptors regulate glutamate release at hippocampal mossy fiber synapses (Pinheiro et al., 2007) . Therefore, it was important to determine the effect of zinc on heteromeric GluK2/GluK3 receptors. To test the specific effects of zinc on GluK2/GluK3 heteromers in cells cotransfected with GluK2 and GluK3, we reduced the likeliness of activating homomeric GluK2 or GluK3 subunits as described previously (Perrais et al., 2009b) . First, the GluK2 b (Q) splice variant was used because of its reduced expression at the cell surface as a homomer (Jaskolski et al., 2004) . Second, GluK3 homomeric receptors were specifically blocked with 1 mM UBP310 (Perrais et al., 2009b) . In cells cotransfected with GluK2 b (Q) and GluK3, application of 1 mM UBP310 inhibited glutamate-activated currents by 55% (n = 6; p < 0.05). The fraction of current resistant to UBP310 was enhanced by zinc (100 mM) to a similar extent (157% ± 7%, n = 18) as for homomeric GluK3 receptors (p = 0.65; Figures 1B and 1C) . The small fraction of homomeric GluK2 receptors at the cell surface would, if anything, lead to an underestimation of the potentiation of GluK2/GluK3 receptors by zinc. Therefore, these results clearly demonstrate that heteromeric GluK2/GluK3 receptors are, like GluK3 receptors, potentiated by zinc.
The modulation of GluK3 by zinc showed a dose-dependent biphasic effect: increasing the concentration of zinc up to 100 mM potentiated currents (half-maximal effect around 20 mM), and higher concentrations progressively inhibited currents ( Figure 1D ). In order to fit the dose-response curve with combined potentiation/inhibition Hill equations, we hypothesized that the inhibition of GluK3 by higher concentrations of zinc was similar to that of GluK2 (a notion supported by the effects of point mutations described in Figure 6 ). This attempt to separate potentiation and inhibition in the GluK3 doseresponse curves yielded an EC 50 value of 46 ± 17 mM, nH 1.82 ± 0.95, and a maximal potentiation of 475% ± 47%, although the moderate quality of the combined fit suggests that potentiation and inhibition might not be independent processes. Surprisingly, zinc potentiated currents mediated by GluK2/GluK3 at all concentrations tested ( Figure 1D) , with an EC 50 of 477 ± 1638 mM, nH 0.6 ± 0.4, consistent with a reduced number of binding sites on heteromeric receptors, and a maximal potentiation of 286% ± 195% of control, and by contrast to homomeric GluK3 receptors, there was no inhibition for zinc concentrations up to 1 mM.
Zinc Changes the Kinetic Properties of GluK3 and Its affinity for Glutamate Zinc could affect GluK3-mediated currents in several ways: it could increase single-channel conductance, increase open probability, allow activation of ''silent'' receptors, or slow down receptor desensitization. It was shown previously that the low glutamate sensitivity of GluK3 receptors was due to fast transitions of glutamate bound receptors to desensitized states (Perrais et al., 2009a) ; hence, a change in desensitization may translate into an increased apparent affinity for glutamate. In order to analyze the mechanisms of zinc potentiation, we characterized key parameters of GluK3 receptor activation using outside-out patches (Figure 2 ). The current decay (t des ) evoked by 100 ms applications was well fitted with single exponential functions, and zinc increased t des in a dose-dependent manner (t des = 5.0 ± 0.2 ms; versus 9.8 ± 0.4 ms, before and after 100 mM zinc, n = 8; p < 0.0001; Figures 2A-2C; see Table S1 available online), whereas it had no effect on GluK2 desensitization (t des = 3.4 ± 0.1 ms versus 3.7 ± 0.1 ms before and after 100 mM zinc, Figure 1 . Zinc Reversibly Facilitates GluK3-Containing KAR Currents in a Dose-Dependent Manner (A) Effect of a sustained application of 100 mM zinc (Zn) on GluK3 (top traces) and GluK2 (bottom traces) currents, evoked by 10 mM glutamate (Glu) for 100 ms and recorded in the whole-cell mode, is shown. (B) Effect of 100 mM zinc on GluK2b/K3 receptors in presence of 1 mM UBP310 to block homomeric GluK3 is illustrated. (C) Histogram presents the effect of 100 mM zinc on GluK2, GluK3, and GluK2/GluK3 receptors. ***p < 0.001, **p < 0.01, *p < 0.05, ns, p > 0.05. norm. amplitude, normal amplitude. (D) Dose-response curves for the effects of zinc on GluK3 (black circles), GluK2 (white circles), and GluK2/GluK3 (black squares) mediated currents elicited by 10 mM glutamate (n = 4-18 for each point) are illustrated. Solid lines show Hill equations (IC 50 = 102 mM, nH = 1.1 for GluK2 and EC 50 = 477 mM, nH = 0.6 and maximum 286% for GluK2b/ K3). The dotted line shows the fit for a combined Hill equation, with an EC 50 of 46 mM for potentiation of GluK3, and an IC 50 of 100 mM, calculated from inhibition for GluK2 (solid line). n = 5; p = 0.20; Figure 2C ) despite its strong effect on GluK2 current amplitudes. Therefore, zinc markedly affects GluK3 receptor desensitization, in contrast to its lack of effect on GluK2 kinetics, suggesting a different mechanism of action. Moreover, zinc increased currents evoked by 1 ms pulses of 10 mM glutamate (191% ± 22% of control amplitude, n = 4; Figure 2D ) and slowed down their deactivation kinetics (from 1.5 ± 0.05 ms to 2.3 ± 0.1 ms, n = 4; p = 0.002; Figure 2E ).
Next, we measured the EC 50 for glutamate in outside-out patches in the absence or presence of zinc (100 mM, Figures  2F and 2G) . Zinc increased the sensitivity of GluK3 receptors for glutamate from an EC 50 of 10.1 ± 1 mM (nH = 1.6 ± 0.1) in control condition to 4.8 ± 1.1 mM (nH = 1.1 ± 0.2) with 100 mM zinc (n = 4). Consequently, zinc is markedly more potent at low glutamate concentrations (1-3 mM) than at 30 mM. In addition, we found that zinc increases the time constants for desensitization at all glutamate concentrations ( Figure 2H ). Finally, zinc speeds up recovery from desensitization (time for half-recovery: 902 ± 1.1 ms and 460 ± 1.2 ms in absence and presence of zinc 100 mM, respectively, n = 5; Figures 2I and 2J) . Hence, our results suggest that zinc, by affecting the fast desensitization properties of GluK3 receptors, enhances GluK3 currents and increases its sensitivity to glutamate.
Reducing Receptor Desensitization Blocks Potentiation by Zinc
Indeed, previous experimental and kinetic modeling data (Perrais et al., 2009a) have shown that fast desensitization of partially liganded GluK3 receptors limits their activation. Therefore, the potentiating effect of zinc should be reduced in GluK3 mutants in which desensitization is slowed or abolished. We directly tested this prediction with two GluK3 mutant receptors that show reduced desensitization (Figure 3 ). We constructed a mutant GluK3 receptor by analogy with a mutant GluK2 receptor with four substitutions (K525E, K696R, I780L, and Q784K) that greatly slowed down desensitization, termed GluK2(ERLK) (Chaudhry et al., 2009; Zhang et al., 2006) . Indeed, GluK3(ERLK) desensitization (15.3 ± 1.9 ms, n = 7; p < 0.0001; Figures 3A and  3D ) was about 3-fold slower than that of wild-type (WT) GluK3, albeit the changes were not as dramatic as with GluK2(ERLK), for which a 50-fold increase is observed (Chaudhry et al., 2009; Zhang et al., 2006) . As predicted, GluK3(ERLK)-mediated currents were inhibited rather than potentiated by zinc (Figures 3A and 3C) with no change in desensitization rate ( Figure 3D ). Another mutant, GluK3(H492C,L753C), for which desensitization is almost entirely suppressed (Perrais et al., 2009a; Weston et al., 2006) , was also inhibited by zinc (100 mM) to a similar extent ( Figures 3B and 3C ). Overall, the potentiating effect of zinc on GluK3 is absent in two variants where GluK3 desensitization is reduced.
Effect of pH on GluK3 Function and Modulation by Zinc
An interaction between zinc modulation and pH has been documented for many zinc binding sites, in particular for NMDA (Choi and Lipton, 1999; Low et al., 2000) and KARs (Mott et al., 2008) . This could reflect the protonation of the zinc binding site or other allosteric mechanisms. Studying the interaction between pH and zinc may provide information on the nature of the site involved in GluK3 potentiation. We have observed a strong effect of pH on GluK3 function: the current amplitude was much smaller at pH 8.3 and slightly higher at pH 6.8 than at pH 7.4. At pH 6.8, in the absence of zinc, there was a slight decrease in rate of desensitization of GluK3 currents (t des 4.7 ± 0.3 ms, n = 11 at pH 7.4, to 6.0 ± 0.5 ms, n = 8 at pH 6.8; p = 0.014). Interestingly, at pH 8.3, we observed a much lower current amplitude and accelerated desensitization (t des 2.7 ± 0.3 ms, n = 9; p < 0.0001; Figures 4A-4C). Application of zinc (100 mM) inhibited currents at pH 6.8 but potentiated currents at pH 8.3 ( Figures 4D-4F ). This suggests that amino acid protonation at pH 6.8, most likely a histidine, might be responsible for the loss of potentiation at low pH.
Facilitatory Effect of Zinc on GluK3 Receptors Is
Mediated by the S2 Extracellular Segment of the LBD In AMPA receptors (AMPARs) and KARs, several studies have shown that residues lining the interface between the LBDs of two adjacent subunits are a key component of dimer stability and regulate desensitization kinetics (Armstrong et al., 2006; Chaudhry et al., 2009; Horning and Mayer, 2004; Nayeem et al., 2009; Sun et al., 2002; Weston et al., 2006) . To identify the zinc binding sites responsible for the facilitatory effect on GluK3 currents, we constructed chimeric receptors of GluK2 and GluK3. Receptors composed of the extracellular domain of GluK3 and the transmembrane and intracellular segments of GluK2 were potentiated by zinc to similar levels as GluK3 (175% ± 9% of control amplitude with 100 mM zinc, n = 5; Figure 5A, left, and Figure 5D ). By contrast, zinc inhibited currents mediated by chimeric receptors that contained the transmembrane and intracellular segments of GluK3 and the extracellular domain of GluK2 (40% ± 8%, n = 4; p = 0.0077; Figure 5A , right, and Figure 5D ). In the GluN2A and GluN2B subunits of NMDARs, the ATD harbors a discrete zinc binding site (Choi and Lipton, 1999; Karakas et al., 2009; Paoletti et al., 2000; Rachline et al., 2005) . GluK3 subunits deleted of their ATD form functional receptors, which fully preserve potentiation by zinc (186% ± 13%, n = 5; p = 0.023; Figures 5B, left and 5D ). Conversely, inhibition is conserved in GluK2 receptors where the ATD was excised (44% ± 11%, n = 4; p = 0.035; Figures 5B, right, and 5D). Thus, this first set of experiments seems to rule out a role of the intracellular region, ion channel, and the ATD of GluK3 and points to the LBD as a potential zinc binding domain responsible for the facilitatory effect of zinc. The LBD is formed by two extracellular segments referred to as S1 and S2 (Stern-Bach et al., 1994) , which form a clamshell-like structure where S1 forms most of the upper half of the clamshell, and S2 forms most of the lower half. We next tested which of these segments is involved in the facilitatory effect of zinc on GluK3 receptors by using chimeric GluK2 and GluK3 receptors where S2 of one is replaced by the other and vice versa. Interestingly, currents mediated by GluK3/GluK2 chimeric receptors that contain S2 and the intracellular part of the GluK2 subunit (GluK3/K2S2) were inhibited (54% ± 6%; n = 5; p = 0.002; Figure 5C , left, and Figure 5D ), whereas currents mediated by GluK3/GluK2 chimeric receptors containing S2 and the intracellular part of the GluK3 subunit (GluK2/K3S2) were facilitated by 100 mM zinc (197% ± 9%, n = 5; p = 0.034; Figure 5C , right, and Figure 5D ). Moreover, whereas desensitization kinetics in control conditions was not affected for most of the constructs tested ( Figure 5E ), the kinetics of GluK3/K2S2 and GluK2/K3S2 was considerably changed (from 5.0 ± 0.2 ms, n = 8 for WT GluK3 to 14.5 ± 0.8 ms, n = 4, p < 0.0001 for GluK3/K2S2; and from 3.4 ± 0.1 ms, n = 5 for WT GluK2 to 2 ± 0.1 ms for GluK2/K3S2, n = 4, p < 0.0001). Slowed desensitization kinetics could explain why GluK3 with the S2 segment substituted for GluK2 is functional as assessed by slow glutamate application on Xenopus oocytes (Strutz et al., 2001) . These experiments clearly point to the S2 segment of GluK3 as a target for zinc binding.
Identification of Key Residues at the Dimer Interface Mediating the Facilitatory Effect of Zinc
To further characterize the zinc binding site, we hypothesized that it might stabilize the interface between LBDs by binding to a unique site generated by amino acids found only in GluK3. Among residues that usually bind zinc (histidine, cysteine, aspartate, and glutamate), a single residue in S2 differs between GluK3 and the other KARs: An aspartate in GluK3 (D759) is replaced by a glycine in GluK1 and GluK2 and by an asparagine in GluK4 and GluK5 ( Figure 6A ). We tested the effects of zinc (100 mM) on the reciprocal mutants GluK3(D759G) and GluK2(G758D). Glutamate-activated currents were potentiated by zinc in GluK2(G758D) receptors to the same extent as GluK3 (177% ± 7% of control amplitude, n = 6; p = 0.008; Figures  6B and 6F) . Conversely, GluK3(D759G) currents were inhibited by zinc (32% ± 9%, n = 5; Figures 6C and 6F) . These results clearly indicate that the replacement of G758 in GluK2 by an aspartate is sufficient to confer zinc potentiation in GluK2. Moreover, desensitization was markedly slower in GluK3 (D759G) (t des = 18.4 ± 1.8 ms; n = 8; p < 0.0001) and greatly accelerated in GluK2(G758D) (t des = 1.3 ± 0.1 ms; n = 6; p < 0.0001; Figure 6G ) compared to WT GluK3 and GluK2, respectively. We observed the same effect when the whole S2 segment was substituted in GluK3/K2S2 and GluK2/K3S2 chimeric receptors ( Figure 5E ). Hence, in addition to its role in the zinc action on GluK3, D759 in GluK3 appears as a key residue to explain the specific desensitization properties of GluK3 as compared to GluK1 and GluK2.
We searched for additional residues involved in the binding of zinc in the vicinity of D759. This residue is localized in the turn between helices J and K of the GluK3 LBD (Venskutonyt _ e et al., 2011), three residues downstream of a conserved histidine near the N terminus of helix K. This conserved histidine, together with D759, is a candidate for residues forming part of the zinc binding site for GluK3. To test this hypothesis, GluK3 H762 was replaced by an alanine. As expected, the facilitatory effect of zinc was turned to an inhibitory effect in GluK3(H762A) (peak amplitude 45% ± 6%, n = 5; p = 0.014; Figures 6D and  6F ), strongly suggesting that H762 participates in the zinc binding site of GluK3 receptors. In addition, the desensitization kinetics of GluK3(H762A) was faster (t des = 3.9 ± 0.1 ms, n = 5; p = 0.0009; Figure 6G ) than for WT GluK3, ruling out an indirect effect of reduced desensitization on the effect of zinc in this mutant.
Structure-Based Analysis of the Zinc Binding Site in GluK3
To obtain further insight into the zinc binding site on GluK3, three independent crystal structures were solved for the GluK3 LBD in the presence of zinc: two in a complex with glutamate, and one in a complex with kainate (Table S2 ). The structure for the six GluK3 protomers in the glutamate complexes was similar to that reported recently by Venskutonyt _ e et al. (2011) but with small variations in the extent of domain closure, from 25.3 to 23.4 , and larger cavity volumes (299 ± 6 Å 3 , mean ± SD, n = 6) than the value of 274 ± 4 Å 3 reported previously, indicating that the LBD of GluK3 is more similar to GluK1 than GluK2, with cavity volumes of 305 and 255 Å 3 , respectively (Mayer, 2005) . For the two protomers in the GluK3 kainate complex ( Figure S1 ), domain closure was 90% and 70% of that induced by glutamate, indicating that the GluK3 LBD can adopt both more closed, and also more open, conformations than observed previously for the GluK3 kainate complex for which a value of 81% was reported by Venskutonyt _ e et al. (2012) . In the crystal forms reported here, the GluK3 protomers assemble as two different dimers, both of which diverge from the canonical arrangement found in full-length GluA2 (Sobolevsky et al., 2009 ). In the P222 1 glutamate and P222 1 kainate complexes, two GluK3 protomers are arranged head to tail such that helix D of subunit A packs against the N terminus of helix K in subunit B ( Figure 7A ). Crystallographic symmetry operations generate a second dimer, arranged in a head-to-head assembly but with a >20 Å lateral displacement of the two protomers such that helix J is packed against helix J of its symmetry mate ( Figure S1C ). In the P2 1 2 1 2 glutamate complex, which has four protomers in the asymmetric unit, both dimer forms are generated by noncrystallographic symmetry.
Calculation of anomalous difference Fourier electron density maps revealed the location of zinc ions that form numerous intermolecular contacts between protomers in both crystal forms ( Figures 7A and S1C) . It is likely that these zinc-mediated contacts play a key role in assembly of the two dimer forms observed in the crystal structures, which could explain why GluK3 failed to pack in the canonical arrangement found in many crystal structures for other iGluR LBDs. However, GluK3 LBD glutamate and kainate complexes, which were crystallized in the absence of zinc ions (Venskutonyt _ e et al., 2011, 2012), were also packed in a noncanonical dimer configuration in the P4 1 space group, highlighting the tendency of KAR LBDs to pack in a variety of nonbiological assemblies, as observed previously for GluK1 and GluK2 (Mayer, 2005; Naur et al., 2005) . Relevant to the zinc potentiation of GluK3, zinc ions were bound at a site labeled Zn1, which was created by D759 in all three crystal forms (Figure 7B) ; the zinc ion at this site was also coordinated by H762, mutation of which abolished potentiation by zinc, and by H492 and E495 located in helix D of the dimer partner subunit. Additional zinc binding sites, which stabilize the alternative dimer assembly, were created by E757 at the base of helix J together with E757 of its symmetry mate (Zn2), by H444 at the N terminus of helix B (Zn3), by E713 in helix I together with H762 and E766 from a symmetry related molecule (Zn4), by H479 at the C terminus of helix C (Zn5), by the main-chain carbonyl oxygen of Glu495 and the side-chain carboxylate of D499 just after the C terminus of helix D (Zn6), by H479 with its symmetry mate (Zn7), and by E441 with H444 of a symmetry-related molecule (Zn8). For most of these sites, the binding of zinc was characterized by short bond lengths, on the order of 1.9-2.0 Å ( Figure 7A ). Although the GluK3 LBD dimer arrangements observed here differ from the canonical arrangement of full-length GluA2 receptors (Sobolevsky et al., 2009) , we tested functionally the involvement of H492, which participates in the Zn1 site (Figure 7B ), but which is absent in other iGluR subunits. We mutated the histidine into a tyrosine, the equivalent residue in GluK2, and also into an alanine. For both GluK3(H492Y) and GluK3(H492A), zinc still potentiated currents (Figures 7D and 7F) . Conversely, GluK2(Y490H) was, like WT GluK2, inhibited by zinc ( Figures  7E and 7F) . Therefore, H492 does not participate in the functional zinc binding site for GluK3 potentiation. This result is consistent with the fact that substitution of the S1 region of GluK2 to GluK3 does not abolish zinc potentiation (Figures 5C and 5D) .
The essentially identical conformation of GluK2 and GluK3 LBD glutamate complexes in crystal forms obtained both in the presence and absence of zinc (Mayer, 2005 ; Venskutonyt _ e et al., 2011), combined with 87% amino acid identity, and 94% amino acid similarity of the GluK2 and GluK3 LBDs, provides a basis for modeling a biological dimer assembly for GluK3, based on GluK2 LBD dimer crystal structures. This approach is further validated by the similar LBD dimer assemblies found in the full-length GluA2 structure (Sobolevsky et al., 2009 Figure 8A ). This model identified D730 as the residue that completes the coordination shell for zinc, together with the main-chain carbonyl oxygen atom of Q756 and the side chains of D759 and H762 from the adjacent subunit, together with one or two water molecules that were not included in the model (Figure 8B ). The resulting structure reveals two key features. First, zinc acts as an intermolecular bridge between the pair of subunits in an LBD dimer assembly. Second, in the absence of zinc, the side chains of D730 and D759, which are separated by only 2.9-3.8 Å , would likely repel each other, destabilizing the dimer assembly and accelerating desensitization. In support of this, neutralizing these charges by mutating D759 into a glycine strongly reduces desensitization. Conversely, introducing a negatively charged aspartate at the equivalent position in GluK2(G758D) markedly accelerates desensitization ( Figures  6B, 6C , and 6G). We suggest that the bound zinc ions act as a countercharge that reduces this repulsive interaction. We tested the prediction that D730 participates in the zinc binding site by constructing the GluK3(D730A) mutant. This receptor was no longer potentiated but rather inhibited by zinc (33% ± 2% of control amplitude, n = 6; p = 0.02; Figures 6E-6G ), whereas the GluK3(D730N) mutant retained zinc potentiation ( Figure 6F ). Therefore, the GluK3 zinc binding site is formed by residues located on two adjacent LBDs. The contribution of two LBD subunits to the zinc binding site explains the potentiation of heteromeric GluK2/GluK3 receptors by zinc (Figures 1B-1D) . In principle, for receptors composed of two GluK2 and two GluK3 subunits, two arrangements are possible: (1) pairs of LBD homodimers, one composed of GluK3 containing two zinc binding sites, with no zinc binding sites in the GluK2 homodimer; and (2) pairs of LBD heterodimers, each containing one zinc binding site formed by residues Q756, D759, and H762 in GluK3 and D729 in GluK2 ( Figure 8C ). To distinguish between these two possibilities, we measured the effect of zinc on receptors composed of GluK2b and GluK3(D730A) in the presence of 1 mM UBP310 to record primarily the activity of heteromeric receptors. Application of zinc (100 mM) led to potentiation of currents ( Figures 8D and  8E ), similar to WT receptors, whereas for GluK3(D730A) mutant homomeric dimers, zinc potentiation was abolished ( Figure 6E ). This result is consistent with hypothesis (2). Moreover, in cells transfected with GluK2b(D729A) and GluK3, zinc did not potentiate currents ( Figures 8D and 8E) , strongly suggesting that the zinc binding site is lost in these heteromeric receptors. Again, this is consistent with hypothesis (2), namely that heteromeric GluK2/GluK3 contains at least an LBD heterodimer and, if composed of two GluK2 and two GluK3 subunits, is arranged as a pair of heterodimers at the level of the LBDs.
DISCUSSION
Our results identify zinc as a positive allosteric modulator of KARs containing the GluK3 subunit and provide a molecular and mechanistic basis for this allosteric modulation. We identify critical amino acids at the interface between the LBD of two partner subunits that form a pocket for zinc binding. Zinc stabilizes the interface by cross-bridging the two partner LBDs in the dimer. By its action as a counter ion that reduces repulsion between opposed aspartate side chains, hence strongly reducing desensitization, zinc binding translates into potentiation of the GluK3 response. Our data also provide a mechanistic and structural explanation for the specific properties of the GluK3 subunit of KARs and reveal important information about KAR architecture. In particular, our study provides a structural explanation for the functional differences between the two closely related KAR subunits GluK2 and GluK3 and about the probable arrangement of subunits in a heteromeric GluK2/ GluK3 receptor, the only native GluK3-containing receptor identified so far (Pinheiro et al., 2007) .
Zinc Acts as a Positive Allosteric Modulator of KARs Containing GluK3
The positive allosteric modulation of KARs by zinc appears as a specific feature of GluK3. Homomeric GluK1 and GluK2, as well as GluK2/GluK4 and GluK2/GluK5, are inhibited by zinc in the concentration range that potentiates GluK3 (this study and Mott et al., 2008) . The properties of GluK3, especially the fast desensitization and low agonist sensitivity, set it apart from the other KARs (Perrais et al., 2010; Schiffer et al., 1997) . We previously showed that the properties of GluK3 are dominant over those of GluK2 when expressed in heteromeric combinations (Perrais et al., 2009a; Pinheiro et al., 2007) . Interestingly, zinc potentiates GluK2/GluK3 receptors as well as GluK3 receptors, indicating that the GluK3 subunit also imposes its allosteric properties on the heteromer. Zinc potentiation appears to act by (E) Traces illustrate the effects of 100 mM zinc on currents evoked by 10 mM glutamate for GluK2(Y490H). (F) Histogram presents the effect of 100 mM zinc on the currents evoked by glutamate for GluK2, GluK3, and point mutants. The asterisks indicate significant difference with control currents without zinc. (G) Histogram presents the desensitization kinetics of GluK2, GluK3, and point mutants recorded in the same conditions as in (E). The asterisks indicate a significant difference with corresponding WT GluK3 or GluK2 receptors. ***p < 0.001, **p < 0.01, *p < 0.05. See also Figure S1 .
reducing the desensitization rate of GluK3. To confirm this link between reduced desensitization and potentiation of the GluK3 response, we showed that the effects of zinc on GluK3 are abrogated in GluK3 variants with reduced desensitization rates. In addition to its potentiating effect, zinc at concentrations above 300 mM for WT GluK3 receptors and for many mutant GluK3 receptors (Table S1 ) clearly inhibits currents. Similar to GluK2, this inhibition is not accompanied by a change in desensitization kinetics, suggesting that these two effects of zinc rely on different mechanisms and, hence, different binding sites. Interestingly, we did not see inhibition of heteromeric GluK2/ GluK3 receptors; moreover, when potentiation is abolished in the GluK2(D729A)/K3 heteromeric receptor, zinc also does not induce any inhibition. This suggests that inhibitory zinc binding sites are screened or absent in heteromeric receptors.
There is a growing number of positive allosteric modulators related to aniracetam and cyclothiazide that bind to the LBD dimer assembly of structurally related AMPARs and that potentiate activity through modification of the deactivation and/or (D) Effect of zinc on currents evoked by glutamate (10 mM) in a cell expressing GluK2b and GluK3(D730A) (top) and in a cell expressing GluK2b(D729A) and GluK3 (bottom). In the former, the potentiation by zinc is preserved, whereas in the latter, the potentiation is lost.
(E) Summary graph of the effect of zinc on heteromeric mutant receptors is presented. ***p < 0.001, **p < 0.01, ns, p > 0.05. desensitization time course (Traynelis et al., 2010 ). The situation is quite different for KARs, for which only concanavalin A (ConA) and a few other plant lectins have been identified as positive allosteric modulators, although not of GluK3 (Perrais et al., 2009a; Schiffer et al., 1997 ). ConA appears to reduce desensitization of KARs and increase the apparent agonist affinity (Partin et al., 1993; Bowie et al., 2003) . There are however clear differences with the mode of action of zinc, including the fact that lectins stabilize different KAR open states (Bowie et al., 2003) and bind to carbohydrate chains in the ATD (Everts et al., 1999) . Moreover, although monovalent ions, such as Na + and Cl À , also regulate the gating of KARs, but not AMPA or NMDARs (Bowie, 2010) , they act as necessary cofactors for KAR function ( Figure 8A ; Plested and Mayer, 2007; Plested et al., 2008) . Finally, protons typically inhibit the function of KARs (Mott et al., 2003; . Here, we show that for GluK3 receptors, desensitization is instead increased at pH 8.3, suggesting that protonation of dimer interface residues stabilizes the LBD dimer assembly. In addition, zinc potentiation is lost at pH 6.8, which suggests that the zinc binding site itself can be protonated, which is likely the case for the key histidine H762.
Zinc Binds GluK3 at the Dimer Interface and Stabilizes the Interaction
We took advantage of the opposite modulation of GluK2 and GluK3 by zinc to narrow down the region responsible for zinc binding. By studying chimeric GluK2/GluK3 receptors and point mutants of the two subunits, we identified key residues in the S2 segment of GluK3 that are responsible for the potentiating effects of zinc. Strikingly, the single mutation D759G in GluK3 reverts zinc potentiation into an inhibition, and the converse mutation in GluK2 imparts potentiation by zinc. In addition to D759, which is unique to GluK3, the binding site for zinc is composed of a carbonyl oxygen from the main chain and two conserved residues: H762 in the same subunit as D759, and D730 in the dimer partner. Prior analysis of the effects of mutations at the LBD dimer interface has confirmed that there is a common mechanism for desensitization in AMPA/KARs, dependent on the stability of the LBD dimer interface (Weston et al., 2006) . We propose that D759 facing D730 induces a destabilization of the dimer interface by electrostatic repulsion (Figure S1D ), generating fast desensitization properties. The binding of zinc to the dimer interface cancels this repulsion and stabilizes the LBD dimer. Consistent with this, GluK3(D759G) desensitizes much more slowly, whereas the converse mutant GluK2(G758D) desensitizes very rapidly. However, mutation of the other aspartate in the zinc binding site, D730, did not yield receptors with reduced desensitization: for GluK3(D730A), desensitization is similar to WT, and for GluK3(D730N), it is even faster than WT (Table S1 ). This unexpected effect could be due, for example, to His762, which would attract Asp730, stabilizing the interaction between LBDs. The presence of Asp759 in the D730A mutant would cancel this effect. Alternatively, structural changes in the mutant receptors could complicate the interpretation. Similar results have been reported for some GluK2 LBD dimer interface mutants, for which the GluK2(E757Q) mutant, which swaps a GluA2 for GluK2 residue, increases desensitization (Chaudhry et al., 2009) , most likely by subtly perturbing the structure of helix J.
Because D730 is conserved between GluK3 and GluK2, it provides an explanation why zinc potentiates heteromeric GluK2/GluK3 receptors, with the zinc binding site partitioning between the two subunits in the dimer. Our structural model suggests that there is only one zinc binding site in a heteromeric LBD dimer (see Figure 8C) . Consistent with this, GluK2/GluK3 receptors have a higher EC 50 and lower nH for zinc than homomeric receptors. Moreover, the analysis of mutant heteromeric receptors shows that zinc binding requires Asp729 on the GluK2 subunit. Consequently, the zinc binding site is most probably shared by GluK2 and GluK3 in LBD heterodimers (model b in Figure 8C ). Asp729 is conserved for all GluK subunits, and therefore, we propose that other combinations of heteromeric receptors containing GluK3 could all comprise a zinc binding site leading to potentiation. Moreover, the GluK3 specificity of potentiation by zinc provides structural insights into the specific gating and desensitization properties of GluK3. Notably, in the LBD of 14 out of 18 iGluR subunits, with the exception of GluK3, GluK4, GluK5, and GluN2D, the turn between helices J and K contains a highly conserved glycine residue. In GluK3, this glycine residue is replaced by D759, producing unique rapid desensitization, whereas in GluK4 and GluK5, the asparagine substitution at this position would likely not destabilize the LBD dimer interface, imparting different gating properties to these receptors.
Functional Consequences
Zinc can modulate excitatory synaptic transmission through multiple mechanisms, which are not all well described (Paoletti et al., 2009) . Although the inhibitory regulation of postsynaptic glutamate receptors, principally NMDARs, appears as a primary function of synaptic zinc, other potential roles in the regulation of synaptic transmission have also been proposed by Paoletti et al. (2009) . Technical limitations have yet precluded a direct measurement of zinc in the synaptic cleft. However, the peak concentration was initially estimated to be in the order of 100 mM (Vogt et al., 2000) . This value is well within the range of efficacy for the allosteric potentiation of GluK3 by zinc but may be overestimated and may depend on experimental conditions (Paoletti et al., 2009) . Moreover, simultaneous application of zinc and glutamate does not potentiate GluK3-mediated currents (data not shown), which likely excludes an effect of zinc during low-frequency stimulation. However, high-frequency trains of synaptic stimulation are thought to trigger a substantial increase in extracellular zinc, and the accumulated zinc could potentiate presynaptic GluK2/GluK3 receptors present at hippocampal mossy fiber synapses (Pinheiro et al., 2007) . Interestingly, it has been shown that vesicular zinc is required for presynaptic LTP at hippocampal mossy fiber synapses by a yet undisclosed mechanism (Pan et al., 2011) . This result can be correlated with the fact that mossy fiber LTP is absent in GluK3 À/À mice (Pinheiro et al., 2007) . The positive allosteric modulation of these presynaptic GluK2/GluK3 receptors may impart increased sensitivity to glutamate and prolonged channel opening, inducing a possible increase in presynaptic Ca 2+ influx.
Hence, allosteric modulation of presynaptic GluK3 receptors may be one of the mechanisms by which zinc promotes presynaptic long-term potentiation.
In conclusion, we have identified zinc as a positive allosteric modulator of presynaptic KARs, with a potential role in synaptic plasticity. Our structure-function analyses lend further support to the notion that the stability of the LBD dimer interface is essential for dictating the desensitization properties of KARs. Our data help explain the fast desensitization properties of GluK3 as compared to GluK2 and pinpoint a single amino acid residue in the upper lobe of the clamshell of the GluK3 LBD, D759, as responsible for the specific properties of GluK3. Finally, the structural data about the site for positive allosteric modulation will be instrumental for the discovery of ligands that may promote synaptic plasticity and cognitive processes by acting on the regulatory KARs.
EXPERIMENTAL PROCEDURES Receptor Mutagenesis
Clones corresponding to rat GluK2a(Q), GluK2b(Q), and GluK3a were described previously (Jaskolski et al., 2004 Pinheiro et al., 2007) . Clones corresponding to GluK2e/3i and GluK3e/2i were described in Perrais et al. (2009a) . Site-directed mutagenesis was performed using QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) with specific oligonucleotides corresponding to each mutant (oligonucleotide forward sequences, primed on their respective WT subunits: GluK3(D759G), 5 0 -GCTGCAGGAGGAGGGCAA
N-terminal deletion versions of GluK2a(Q) and GluK3a(Q) were generated using restriction site addition by PCR before the amino acid sequence GRI at positions 344 and 347, respectively: GluK2 DATD: forward 5 0 -GAATTCCGG CAGAATAACATTT AACAAAACCAATGG-3 0 , reverse 5 0 -CACCAAATGC CTC CCACTATC-3 0 primed on GluK2a ; GluK3 DATD: forward: 5 0 -GAATTCAG GACGGATTGTTTTCAACAAAACCAGTGGC-3 0 , reverse 5 0 -GGCTTAGAGAA GTCAATGGCCTCCTCTCGGACATGGG-3 0 primed on GluK3a.
The GluK2/3S2 and GluK3/2S2 chimeras were constructed by exchange of the C-terminal domain of one GluK subunit to the other one using the EcoRV restriction site already present on GluK2 in position 532 on the first transmembrane domain and one created by mutagenesis into the same amino acid sequence in position 534 on GluK3 with a forward primer of 5 0 -CCCCC TGTCCCCAGATATCTGGATGTACGTGC-3 0 . All DNAs were verified by restriction analysis and sequencing.
Cell Culture and Transfection HEK293 cells (European Collection of Cell Cultures) were grown and transfected as previously described by Coussen et al. (2005) . Cells were cotransfected using FuGENE 6 (Roche) with green fluorescent protein (GFP) and GluK2a(Q), GluK3a, or mutated forms of these receptors at a cDNA ratio of 1:3. For experiments on heteromeric GluK2/GluK3 receptors, cells were transfected with GFP, GluK2b(Q), and GluK3a at a DNA ratio of 1:1.5:1.5. Cells were used 1-3 days after transfection and replated the day before recording for lifted cells, or 1-2 days before recording for outside-out patches.
Electrophysiological Recordings
Brightly fluorescent, isolated cells were selected for recording. Cells were bathed in a solution containing the following: 145 mM NaCl, 2 mM KCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES, adjusted to 320 mOsm/l and pH 7.4 with NaOH, at room temperature. Recording pipettes (resistance 3-5 MU) were filled with a solution containing the following: 130 mM CsCH 3 SO 3 , 2 mM NaCl, 2 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES, 4 mM Na 2 ATP, and 0.1 mM spermine, adjusted to 310 mOsm/l, and pH 7.2 with CsOH. Cells were recorded at room temperature (22 C-25 C), in whole-cell or outside-out patch mode, held at À80mV to À40mV, and placed under the flow of a theta tube pulled to a final opening of $100 mm mounted on a piezoelectric translator (P-245.50 and E-470 amplifier; Polytec PI). Currents were evoked by long (100 ms) or short (1 ms) applications of glutamate every 20 s and were filtered at 2.9 kHz and recorded at a sampling frequency of 20 kHz by an EPC10 amplifier (HEKA). Up to four different glutamate concentrations, or three zinc concentrations, were applied to a cell or an outside-out patch with a manual valve. Zinc (ZnCl 2 ) was added in both control and glutamate solutions. The exchange between two different concentrations was completed within 2 min. All chemicals were from Sigma-Aldrich. UBP310 was from Tocris.
Data Analysis
All electrophysiological recordings were analyzed with IGOR Pro 5 (WaveMetrics). Current amplitudes were measured with built-in tools, and t des was measured with exponential fit using a least-squares algorithm. For each condition, we averaged five sweeps and corrected amplitude changes for run down. Statistical analysis was performed using GraphPad (Prism). In the text and figures, data are presented as mean ± SEM; Student's t test was used for assessment of difference, with the following coding: ***p < 0.001, **p < 0.01, *p < 0.05, ns p > 0.05. The actual p value is indicated for critical tests.
Crystallography
The GluK3 LBD construct was created by PCR from the full-length cDNA and contained residues N402-K515 in S1 connected via a GT linker to P638-E776 in S2, with an N-terminal His8 affinity tag and LVPRGS thrombin site. The GluK3 LBD was expressed as a soluble protein in Origami B(DE3) E. coli and purified as described previously for other KAR LBD constructs (Mayer, 2005) . Crystals were grown using hanging drops in the presence of either 5 mM glutamate or 4 mM kainate, together with 2-10 mM zinc acetate added to the protein solution at 5-10 mg/ml in a buffer containing 200 mM NaCl, 10 mM HEPES (pH 7), and 1 mM EDTA. The reservoir solution for the glutamate complexes contained 6%-14% PEG 3350, 100 mM Bis-Tris propane (pH 8.4-8.5), and 0.2 M Na 2 SO 4 . For the kainate complexes, the reservoir contained 4%-6% PEG 8K and 0.1 M Tris (pH 7.8). Crystals were cryoprotected by serial transfers to artificial mother liquor containing 18%-22% glycerol. X-ray diffraction data were collected from single crystals at 100 K at APS 22-ID. Data sets were indexed, scaled, and merged using DENZO and SCALEPACK from the HKL2000 suite (Otwinowski and Minor, 1997) . None of the data sets showed twinning as analyzed by PHENIX xtriage (Adams et al., 2010) . For the glutamate complex, two different crystal forms were obtained; the kainate complex was isomorphous with one of the glutamate complexes (Table S2 ). The structures were solved by molecular replacement using Phaser (McCoy et al., 2007) with a GluR6 LBD monomer (PDB 1S50) as a search probe. The solution found two protomers with high rotation and translation Z scores for the glutamate P222 1 (RFZ1 = 15.5, TFZ1 = 17.4; RFZ2 = 17.4 and TFZ2 = 52.4) and kainate P222 1 (RFZ1 = 12.1, TFZ1 = 20.5; RFZ2 = 14.8, TFZ2 = 40.8) complexes. For the second crystal form of the glutamate complex in the P2 1 2 1 2 space group, the molecular replacement solution located four protomers, also with high Z scores (RFZ1 = 13.8, TFZ1 = 17.6; RFZ2 = 18.6 and TFZ2 = 31.4; RFZ3 = 13.0, TFZ3 = 61.8; RFZ4 = 13.0 and TFZ4 = 67.1). The models were initially built using ARP/wARP (Morris et al., 2003) and then refined by alternate cycles of crystallographic refinement with PHENIX (Adams et al., 2010) coupled with rebuilding and real-space refinement with Coot (Emsley and Cowtan, 2004) using TLS groups determined by motion determination analysis (Painter and Merritt, 2006) . The final models (Table S2) were validated with MolProbity (Davis et al., 2004) . Figures were prepared using PyMOL (Schrö dinger).
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